Anlon Healthcare Ltd vs Jubilant Ingrevia Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 112.35 as of 24 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Jubilant Ingrevia Ltd changed from 76.6 on March 2021 to 40.9 on March 2025 . This represents a CAGR of -11.79% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Jubilant Ingrevia Ltd changed from ₹ 4158 crore on March 2021 to ₹ 10350 crore on March 2025 . This represents a CAGR of 20.01% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 1060 crore as compare to the Sep '25 revenue of ₹ 1131 crore. This represent the decline of -6.29% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 122.91 crore as compare to the Sep '25 ebitda of ₹ 146.25 crore. This represent the decline of -15.96% The net profit of Anlon Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Jubilant Ingrevia Ltd changed from ₹ 48.74 crore to ₹ 46.9 crore over 7 quarters. This represents a CAGR of -2.17% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jubilant Ingrevia Ltd changed from 14.45 % on March 2021 to 30.24 % on March 2025 . This represents a CAGR of 15.92% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Jubilant Ingrevia Ltd

Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh.
The name of the Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services.

FAQs for the comparison of Anlon Healthcare Ltd and Jubilant Ingrevia Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Jubilant Ingrevia Ltd?

Market cap of Anlon Healthcare Ltd is 597 Cr while Market cap of Jubilant Ingrevia Ltd is 9,130 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Jubilant Ingrevia Ltd?

The stock performance of Anlon Healthcare Ltd and Jubilant Ingrevia Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Jubilant Ingrevia Ltd?

As of March 24, 2026, the Anlon Healthcare Ltd stock price is INR ₹112.35. On the other hand, Jubilant Ingrevia Ltd stock price is INR ₹573.25.

How do dividend payouts of Anlon Healthcare Ltd and Jubilant Ingrevia Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Jubilant Ingrevia Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.